Has Jay Montgomery, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,713 in general payments to Jay Montgomery, MD across 61 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jay Montgomery, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jay Montgomery, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jay Montgomery, MD

Internal Medicine · Nashville, TNNPI 1639343346

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (37.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 60.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $6,923 and has fallen 70.8% since, to $2,023 in 2025. Among internal medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,713in general payments, 2019–2025

Across 61 payments — averaging $175.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$6K
Abbott$3K
Biotronik Inc.$928
Philips North America LLC$364
Boston Scientific$248
Atricure, Inc.$139
plus $27 from 1 others

$163,406in research payments, 2019–2025

Across 39 payments — averaging $4189.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$145K
Boston Scientific$18K

What the payments were for

Consulting fees$4,00037%
Travel & lodging$3,69534%
Food & beverage$3,01828%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	23	$6,433
Abbott	17	$2,574
Biotronik Inc.	13	$928
Philips North America LLC	3	$364
Boston Scientific	2	$248
Atricure, Inc.	1	$139
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Allure CRT Pacemaker$2,149
EVERA MRI XT DR SURESCAN$1,130
AMPLATZER AMULET$279
Micra$245
INTELLAMAP ORION$173
(9124) LM Undivided$150
Acticor$146
Edora$146
Solia$146
Rivacor$146
BioMonitor$146
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$139
AURORA EV-ICD MRI SURESCAN$129
SLS$124

How this compares

$10,713 in reported general payments places this provider in the 95th percentile of 2,216 internal medicine providers in Tennessee.

See all internal medicine providers in Tennessee →

Medicare billing

Part B allowed, 2024

$137,953

Medicare patients

2,145

Services billed

3,516

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	211	$283,730
XareltoRivaroxaban	28	$27,491
Dabigatran EtexilateDabigatran Etexilate Mesylate	22	$7,400
PradaxaDabigatran Etexilate Mesylate	11	$4,195
Amiodarone Hcl	45	$2,793
Metoprolol Succinate	185	$2,610
Flecainide Acetate	45	$1,381
Diltiazem 24hr Er (Cd)Diltiazem Hcl	26	$698
Potassium Chloride	19	$568
SotalolSotalol Hcl	27	$496
Furosemide	31	$294
Metoprolol Tartrate	18	$133
Hydrochlorothiazide	11	$126
Losartan Potassium	12	$122
Carvedilol	13	$82

Paid to pharmacies, not to this prescriber.

Other internal medicine in Nashville

John AndersonNashville$1.5M
Temidayo AbeNashville$113K
Wayne RileyNashville$86K
Leah CordovezNashville$64K
Asad Al AboudNashville$44K
Mark KouryNashville$41K
David HeusinkveldNashville$24K
Charlotte LohreyNashville$19K
Malek Al-OmaryNashville$18K
James GekasNashville$17K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →